{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T12:46:32Z","timestamp":1772196392110,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.vaccine.2008.10.021","type":"journal-article","created":{"date-parts":[[2008,10,27]],"date-time":"2008-10-27T08:05:10Z","timestamp":1225094710000},"page":"80-87","source":"Crossref","is-referenced-by-count":14,"title":["An IL-12 DNA vaccine co-expressing Yersinia pestis antigens protects against pneumonic plague"],"prefix":"10.1016","volume":"27","author":[{"given":"Hitoki","family":"Yamanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teri","family":"Hoyt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinghong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Crist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Golden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Maddaloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.10.021_bib1","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1128\/CMR.17.2.434-464.2004","article-title":"Intraspecific diversity of Yersinia pestis","volume":"17","author":"Anisimov","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2008.10.021_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.10.1.35","article-title":"Yersinia pestis\u2014Etiologic agent","volume":"10","author":"Perry","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2008.10.021_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.idc.2006.02.004","article-title":"Plague: disease, management, and recognition of act of terrorism","volume":"20","author":"Koirala","year":"2006","journal-title":"Infect Dis Clin N Am"},{"key":"10.1016\/j.vaccine.2008.10.021_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4049\/jimmunol.68.2.131","article-title":"Studies on immunisation against plague","volume":"68","author":"Baker","year":"1952","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.10.021_bib5","first-page":"408","article-title":"An usual strain of Pasteurella pestis isolated from a fatal human case of plague","volume":"23","author":"Winter","year":"1960","journal-title":"Bull WHO"},{"key":"10.1016\/j.vaccine.2008.10.021_bib6","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1084\/jem.20020908","article-title":"Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression","volume":"196","author":"Sing","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2008.10.021_bib7","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1128\/IAI.63.8.2854-2858.1995","article-title":"Active immunisation with V-antigen from Yersinia pestis protects against plague","volume":"63","author":"Leary","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.10.021_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1574-695X.1998.tb01168.x","article-title":"Macromolecular organisation of recombinant Yersinia pestis F1 antigen and effect of structure on immunogenicity","volume":"21","author":"Miller","year":"1998","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2008.10.021_bib9","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0264-410X(98)80110-2","article-title":"Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine","volume":"16","author":"Heath","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.10.021_bib10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1574-695X.1995.tb00196.x","article-title":"A new improved sub-unit vaccine for plague: the basis of protection","volume":"12","author":"Williamson","year":"1995","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2008.10.021_bib11","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0264-410X(96)00303-9","article-title":"A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washing and protects immunized animals against pneumonic plague","volume":"15","author":"Williamson","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.10.021_bib12","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0264-410X(96)00151-X","article-title":"Local and systemic immune response to a microencapsulated sub-unit vaccine for plague","volume":"14","author":"Williamson","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.10.021_bib13","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1128\/IAI.73.11.7304-7310.2005","article-title":"Cell-mediated protection against pulmonary Yersinia pestis infection","volume":"73","author":"Parent","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.10.021_bib14","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1128\/IAI.00185-06","article-title":"Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral defense against lethal pulmonary Yersinia pestis infection","volume":"74","author":"Parent","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.10.021_bib15","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1128\/IAI.01529-06","article-title":"Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection","volume":"75","author":"Philipovskiy","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.10.021_bib16","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/eji.200324038","article-title":"The role of interleukin-12 in human infectious diseases: only a faint signature","volume":"33","author":"Fieschi","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2008.10.021_bib17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.immunol.16.1.495","article-title":"The interleukin-12\/interleukin-12-receptor system: Role in normal and pathogenic","volume":"16","author":"Gately","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2008.10.021_bib18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1126\/science.8097338","article-title":"Development of TH1 CD4+ T cell through IL-12 produced by Listeria-induced macrophages","volume":"260","author":"Hsieh","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2008.10.021_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-3083.2002.01101.x","article-title":"IL-12: the role of p40 versus p75","volume":"56","author":"Abdi","year":"2002","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2008.10.021_bib20","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1128\/IAI.00581-08","article-title":"A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague","volume":"76","author":"Yamanaka","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.10.021_bib21","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.4049\/jimmunol.178.2.1059","article-title":"Oral vaccination with Salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague","volume":"178","author":"Yang","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.10.021_bib22","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1128\/IAI.70.8.4273-4281.2002","article-title":"Fimbriated Salmonella enterica serovar Typhimurium abates initial inflammatory responses by macrophages","volume":"70","author":"Pascual","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.10.021_bib23","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.4049\/jimmunol.178.3.1791","article-title":"Regulatory T cell vaccination without autoantigen protects against experimental autoimmune encephalomyelitis","volume":"178","author":"Ochoa-Rep\u00e1raz","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.10.021_bib24","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1128\/IAI.73.11.7297-7303.2005","article-title":"Selection of protective epitopes for Brucella melitensis using DNA vaccination","volume":"73","author":"Yang","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.10.021_bib25","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-0684.2005.00124.x","article-title":"SIV DNA vaccine co-administered with IL-12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques","volume":"34","author":"Boyer","year":"2005","journal-title":"J Med Primatol"},{"key":"10.1016\/j.vaccine.2008.10.021_bib26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1089\/aid.2005.21.629","article-title":"Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus","volume":"21","author":"Egan","year":"2005","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.vaccine.2008.10.021_bib27","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.vaccine.2005.08.103","article-title":"DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation","volume":"24","author":"Yoshida","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.10.021_bib28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.virol.2005.12.029","article-title":"Immunization of rhesus macaques with a polyvalent DNA prime\/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype","volume":"348","author":"Pal","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.10.021_bib29","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.vaccine.2003.09.020","article-title":"Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen","volume":"22","author":"Garmory","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.10.021_bib30","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1016\/j.vaccine.2004.02.036","article-title":"A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague","volume":"22","author":"Wang","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.10.021_bib31","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1128\/IAI.71.1.374-383.2003","article-title":"Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen","volume":"71","author":"Grosfeld","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.10.021_bib32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2249.1999.00859.x","article-title":"An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model","volume":"116","author":"Williamson","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2008.10.021_bib33","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.4049\/jimmunol.155.10.4621","article-title":"Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4","volume":"155","author":"Marinaro","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.10.021_bib34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1084\/jem.181.1.41","article-title":"Impaired mucosal immune responses in interleukin 4-targeted mice","volume":"181","author":"Vajdy","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2008.10.021_bib35","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4049\/jimmunol.162.1.114","article-title":"Use of intranasal IL-12 to target predominantly Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxin","volume":"162","author":"Marinaro","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.10.021_bib36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/019262339902700112","article-title":"The toxicology of interleukin-12: a review","volume":"27","author":"Car","year":"1999","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.vaccine.2008.10.021_bib37","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.4049\/jimmunol.161.8.4195","article-title":"Weak anamnestic responses of inbred mice to Yersinia F1 genetic vaccine are overcome by boosting with F1 polypeptide while outbred mice remain nonresponsive","volume":"161","author":"Brandler","year":"1998","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08014011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08014011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T18:11:32Z","timestamp":1684606292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08014011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0264410X08014011"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.10.021","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}